1
|
Details of the person discharging managerial responsibilities / person closely associated
| ||
a)
|
Name
|
Aradhana Sarin
| |
2
|
Reason for the notification
| ||
a)
|
Position/status
|
Chief Financial Officer
| |
b)
|
Initial notification/Amendment
|
Initial notification
| |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
a)
|
Name
|
AstraZeneca PLC
| |
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
| |
4i
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
AstraZeneca PLC American Depositary Shares
CUSIP: 046353108
| |
b)
|
Nature of the transaction
|
Acquisition of AstraZeneca PLC American Depository Shares pursuant to a vesting under the Global Restricted Stock Plan
| |
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
0
|
67,523
| ||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
| |
e)
|
Date of the transaction
|
29 July 2022
| |
f)
|
Place of the transaction
|
Outside a trading venue
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
AstraZeneca plc published this content on 01 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 August 2022 15:14:07 UTC.